246 related articles for article (PubMed ID: 22920307)
1. Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639].
Gasparovic H; Petricevic M; Kopjar T; Djuric Z; Svetina L; Biocina B
Trials; 2012 Aug; 13():148. PubMed ID: 22920307
[TBL] [Abstract][Full Text] [Related]
2. Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639).
Petricevic M; Kopjar T; Gasparovic H; Milicic D; Svetina L; Zdilar B; Boban M; Mihaljevic MZ; Biocina B
J Thromb Thrombolysis; 2015 May; 39(4):522-31. PubMed ID: 25095738
[TBL] [Abstract][Full Text] [Related]
3. Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.
Gasparovic H; Petricevic M; Kopjar T; Djuric Z; Svetina L; Biocina B
Am J Cardiol; 2014 May; 113(10):1660-7. PubMed ID: 24666617
[TBL] [Abstract][Full Text] [Related]
4. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
5. Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial.
Rafiq S; Johansson PI; Zacho M; Stissing T; Kofoed K; Lilleør NB; Steinbrüchel DA
Trials; 2012 Apr; 13():48. PubMed ID: 22540524
[TBL] [Abstract][Full Text] [Related]
6. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
[TBL] [Abstract][Full Text] [Related]
7. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.
Fitchett D; Eikelboom J; Fremes S; Mazer D; Singh S; Bittira B; Brister S; Graham J; Gupta M; Karkouti K; Lee A; Love M; McArthur R; Peterson M; Verma S; Yau T
Can J Cardiol; 2009 Dec; 25(12):683-9. PubMed ID: 19960127
[TBL] [Abstract][Full Text] [Related]
8. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.
Mrdovic I; Savic L; Krljanac G; Asanin M; Cvetinovic N; Brdar N; Stojanovic M; Djuricic N; Stankovic S; Marinkovic J; Perunicic J
J Interv Cardiol; 2013 Jun; 26(3):221-7. PubMed ID: 23373620
[TBL] [Abstract][Full Text] [Related]
10. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME
J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
Kulik A; Chan V; Ruel M
Expert Opin Drug Saf; 2009 Mar; 8(2):169-82. PubMed ID: 19309245
[TBL] [Abstract][Full Text] [Related]
14. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
Deo SV; Dunlay SM; Shah IK; Altarabsheh SE; Erwin PJ; Boilson BA; Park SJ; Joyce LD
J Card Surg; 2013 Mar; 28(2):109-16. PubMed ID: 23488578
[TBL] [Abstract][Full Text] [Related]
15. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
[TBL] [Abstract][Full Text] [Related]
16. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
17. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
18. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
